Immediate Impact
1 from Science/Nature 55 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
Works of Peter Lee being referenced
Update On The Long-Term Efficacy and Safety Of Momelotinib, a JAK1 and JAK2 Inhibitor, For The Treatment Of Myelofibrosis
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Peter Lee | 45 | 34 | 10 | 53 | 41 | 37 | 302 | |
| Francis Lobo | 41 | 1 | 1 | 49 | 21 | 36 | 370 | |
| Farnam Mohebi | 17 | 10 | 1 | 40 | 6 | 28 | 341 | |
| Tu My To | 19 | 4 | 11 | 51 | 13 | 41 | 344 | |
| Abiola Oladapo | 59 | 24 | 4 | 30 | 8 | 30 | 346 | |
| Dina N. K. Boulos | 15 | 7 | 1 | 59 | 18 | 24 | 321 | |
| Karen Murray | 12 | 5 | 10 | 57 | 3 | 32 | 339 | |
| Johan Mesterton | 87 | 3 | 4 | 90 | 9 | 25 | 308 | |
| Tomasz Hermanowski | 152 | 21 | 3 | 101 | 25 | 49 | 321 | |
| Marie Dalichampt | 27 | 4 | 1 | 28 | 41 | 23 | 365 | |
| Miguel Murat Vasconcellos | 32 | 21 | 3 | 124 | 15 | 19 | 311 |
All Works
Login with ORCID to disown or claim papers
Loading papers...